Endocrinology
From the Journals
Meta-analysis supports cardiovascular benefits of EPA
Omega-3 fatty acids improved cardiovascular outcomes, with a greater risk reduction in studies of eicosapentaenoic acid alone rather than combined...
News
New drug, finerenone, approved for slowing kidney disease in diabetes
Finerenone (Kerendia) is the first agent approved from a novel class, the nonsteroidal mineralocorticoid receptor antagonists. But its role in...
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
Conference Coverage
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes...
News
FDA: More metformin extended-release tablets recalled
News
AHA: Physical activity best first-line for high BP, cholesterol
Advice to sit less and move more is a critical component of first-line treatment for patients with mild to moderate hypertension and elevated...
From the Journals
Waist circumference a marker for NAFL in type 1 diabetes
A cross-sectional study has found that waist-to-height ratio is a sensitive marker for nonalcoholic fatty liver in type 1 diabetes.
Conference Coverage
‘Remarkable’ response to diabetes drug in resistant bipolar depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after metformin...
From the Journals
A1c below prediabetes cutoff linked to subclinical atherosclerosis
Hemoglobin A1c below prediabetes levels is a potential biomarker for subclinical atherosclerosis, a European observational study reports.
Conference Coverage
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.